We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Saturday
May 13
15:15 - 16:30
Business Suite 3-4
Current challenges in proton therapy
Laura Toussaint, Denmark
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.
1450
Poster Discussion
Physics
Comparison of static and dynamic proton arc treatment planning algorithms in oropharyngeal cancer
Bas A. de Jong, The Netherlands
PD-0242
Proof-of-concept: Novel CBCT-based adaptive robust optimization in sinonasal cancer proton therapy
Nadine Vatterodt, Denmark
PD-0243
Systematic analysis of bone marrow sparing for the treatment of cervical cancer with IMPT
Sander Kuipers, The Netherlands
PD-0244
A concept for ion type-independent RBE modelling in proton and light ion therapy
Liheng Tian, Germany
PD-0245
Can combined proton-photon therapy improve plan robustness against breathing motion?
Florian Amstutz, Switzerland
PD-0246
Clinical suitability of CBCT-based synthetic CTs in proton therapy for head and neck patients
Rutger de Koster, The Netherlands
PD-0247
Can surface imaging predict the impact of anatomical deformations on proton breast treatment?
Vincent Hamming, The Netherlands
PD-0248
Automatic deep learning treatment planning of gradient-optimized match fields for PBS proton therapy
Gunnar Arthur Helgason, Sweden
PD-0249
Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy
Saber Nankali, Denmark
PD-0250
Clinical implementation of deep learning automated robust IMPT planning for oropharyngeal cancer
Ilse van Bruggen, The Netherlands
PD-0251
2D dosimetric impact of an in-beam MR magnetic field on scanned proton pencil beam spot fields
Benjamin Gebauer, Germany
PD-0252
Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations
Vivek Maradia, Switzerland
PD-0253